Johnson & Johnson takes responsibility for Baltimore vaccine mix-up

WASHINGTON  — Johnson & Johnson is taking over “full responsibility” for a subcontractor’s Baltimore facility that produces the drug substance for its single dose COVID-19 vaccine after an embarrassing mix-up.
The company says it’s adding leaders in operations and quality control to the Emergent BioSolutions plant to supervise the work of its vaccine line.
It comes after enough drug substance for about 15 million doses was contaminated by human error at the plant. The issue was flagged to federal regulators, who have yet to approve any doses from the Baltimore plant, last week.